Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
iShares US Consumer Staples ETF
IYK
$1.33B
| $1.13M | ﹤0.01% |
+17,700
| New | +$1.13M |
|
2327
Atossa Therapeutics
ATOS
$108M
| $1.13M | ﹤0.01% |
1,284,270
+41,900
| +3% | +$36.9K |
|
2328
Community Health Systems
CYH
$412M
| $1.13M | ﹤0.01% |
360,900
+307,773
| +579% | +$964K |
|
2329
SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$14.4B
| $1.13M | ﹤0.01% |
23,200
+11,100
| +92% | +$541K |
|
2330
Larimar Therapeutics
LRMR
$336M
| $1.12M | ﹤0.01% |
247,042
+1,700
| +0.7% | +$7.74K |
|
2331
Children's Place
PLCE
$155M
| $1.12M | ﹤0.01% |
48,360
-84,100
| -63% | -$1.95M |
|
2332
Carter Bankshares
CARE
$450M
| $1.12M | ﹤0.01% |
74,800
-4,200
| -5% | -$62.9K |
|
2333
Xponential Fitness
XPOF
$313M
| $1.12M | ﹤0.01% |
+86,900
| New | +$1.12M |
|
2334
iShares Fallen Angels USD Bond ETF
FALN
$1.88B
| $1.12M | ﹤0.01% |
+42,300
| New | +$1.12M |
|
2335
Neuropace
NPCE
$326M
| $1.12M | ﹤0.01% |
108,325
+64,040
| +145% | +$660K |
|
2336
Zevra Therapeutics
ZVRA
$435M
| $1.12M | ﹤0.01% |
170,500
+37,800
| +28% | +$248K |
|
2337
Epsilon Energy
EPSN
$120M
| $1.11M | ﹤0.01% |
219,300
-58,500
| -21% | -$297K |
|
2338
GSI Technology
GSIT
$98M
| $1.11M | ﹤0.01% |
421,607
-52,443
| -11% | -$138K |
|
2339
ProPhase Labs
PRPH
$18M
| $1.11M | ﹤0.01% |
245,710
-38,300
| -13% | -$173K |
|
2340
LENSAR
LNSR
$149M
| $1.1M | ﹤0.01% |
314,438
+4,993
| +2% | +$17.5K |
|
2341
First Trust NASDAQ-100 Equal Weighted Index Fund
QQEW
$1.88B
| $1.1M | ﹤0.01% |
9,400
+3,800
| +68% | +$446K |
|
2342
VanEck Rare Earth/Strategic Metals ETF
REMX
$735M
| $1.1M | ﹤0.01% |
+17,935
| New | +$1.1M |
|
2343
Greif
GEF
$3.59B
| $1.1M | ﹤0.01% |
16,800
-13,300
| -44% | -$872K |
|
|
GOGL
2344
DELISTED
Golden Ocean Group
GOGL
| $1.1M | ﹤0.01% |
112,854
-311,415
| -73% | -$3.04M |
|
2345
Reading International Class A
RDI
$33.8M
| $1.1M | ﹤0.01% |
576,690
-2,300
| -0.4% | -$4.39K |
|
|
THRX
2346
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $1.1M | ﹤0.01% |
271,600
+145,406
| +115% | +$589K |
|
2347
Agilon Health
AGL
$443M
| $1.1M | ﹤0.01% |
87,500
-410,300
| -82% | -$5.15M |
|
2348
Amicus Therapeutics
FOLD
$2.46B
| $1.1M | ﹤0.01% |
77,400
-71,000
| -48% | -$1.01M |
|
|
SCWX
2349
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $1.1M | ﹤0.01% |
148,340
+14,600
| +11% | +$108K |
|
|
GAN
2350
DELISTED
GAN Ltd
GAN
| $1.09M | ﹤0.01% |
692,027
+215,610
| +45% | +$341K |
|